ERIN LANGE-VANDELLO: Open Payments
NPI 1922024819 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,204 in 61 payments from 13 companies in 2025. Trend: 2023 $1,666 · 2024 $1,614 · 2025 $1,204
Food & beverage: $1,204
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $410 |
| AstraZeneca Pharmaceuticals LP | 6 | $185 |
| Astellas Pharma US Inc | 4 | $110 |
| Amgen Inc. | 6 | $95 |
| ABBVIE INC. | 4 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| Esperion Therapeutics, Inc. | 3 | $55 |
| PFIZER INC. | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
Products named: Wegovy, AIRSUPRA, Ozempic, Veozah, VRAYLAR, JARDIANCE, OTEZLA, NEXLETOL.
Industry payments across FL — which companies pay providers there.
